Imm-101 (Not yet branded)
Other Medications
Description
IMM-101 is a heat-killed whole-cell mycobacterial immunotherapy derived from Mycobacterium obuense that functions as an immune system activator. It is designed to stimulate the innate immune system and enhance anti-tumor immunity when combined with standard cancer treatments. In colorectal cancer, IMM-101 has been evaluated in combination with standard of care therapies for patients with metastatic or unresectable disease.
Mechanism of Action
IMM-101 works by activating toll-like receptors and other pattern recognition receptors on immune cells, triggering a cascade of innate immune responses. This activation leads to enhanced macrophage function, increased cytokine production, and improved antigen presentation, ultimately promoting a more robust anti-tumor immune response when used along
Molecular Targets
Side Effects
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.
Clinical Trials
Quick Info
| Brand Name | Not yet branded |
| Category | Other Medications |
 Status | Experimental |
 EMA Status | Experimental |
 Spain Access | Not available |
| Administration | Intramuscular |
| Clinical Trials | 1 |
Related Medications
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.